SI-BONE, Inc. (SIBN) financial statements and ratios from SEC XBRL: revenue $200.93M (TTM), net margin -9.4%, revenue growth 20.2% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $200.93M |
| Net Margin | -9.4% |
| Revenue Growth (YoY) | 20.2% |
| EPS Growth (YoY) | -41.3% |
| FCF Growth (YoY) | -60.3% |
| Price / Book | 4.78 |
| Price / Sales | 4.16 |
| FCF Yield | -2.4% |
| Altman Z-Score | 7.30 (safe) |
| Piotroski F-Score | 6/9 |
| Sector P/E (Healthcare) | 21.6 |
SIBN overview · SIBN earnings · SIBN KPIs · SIBN investor relations · SIBN ownership · SIBN peers · SIBN filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.